Australis Capital

What Australis Capital does

Australis Capital Inc. is a publicly traded investment company (CSE: AUSA; OTCQB: AUSAF) that creates shareholder value through early-stage, opportunistic, and diversified investments in the cannabis value chain in the United States and abroad. Rather than operating a discrete product line, the firm identifies and invests in cannabis businesses through equity, debt, royalties, distribution-stream financings, and control share acquisitions of both public and private companies. Its go-to-market is sales-led and portfolio-driven, with the company explicitly aligned with Aurora Cannabis — at the time one of the world's largest publicly traded cannabis producers with 500,000+ kg/year of funded production capacity — to lend deal-flow credibility and brand recognition.

The company's "product" is its portfolio. Notable positions include Folium Biosciences (the then-largest US vertically integrated hemp-derived phytocannabinoid producer), Mr. Natural Productions (a California cannabis brand with certified-organic, high-THC products acquired outright), Quality Green (a Canadian ACMPR-licensed producer taken public via Australis as lead investor), Body and Mind Inc. / ShowGrow (Nevada cultivation and California dispensary chain), Wagner Dimas (Nevada-based large-scale pre-roll hardware used by 40+ major cannabis brands), and Rthm Technologies (a mobile health genetics and circadian rhythm app). Underlying technology is conventional financial/investment technology — portfolio management, deal sourcing, and capital markets execution — rather than a proprietary technology platform. Its core operating edge is the experience base of a small (11-50 person) leadership team recruited from gaming, fintech, gambling, and regulated-industry backgrounds (NYSE/NASDAQ officers, Mattel corporate development, Bally/Scientific Games/EY-trained finance), giving the firm unusually deep cross-disciplinary regulatory expertise for a sub-50-person cannabis specialist.

Revenue mechanics are investment returns rather than product pricing: capital appreciation, royalty/distribution streams, and transaction-related gains from portfolio companies. Distribution is via dual-listed publicly traded shares accessible through both the Canadian Securities Exchange (primary listing) and the US OTCQB market (commenced February 2019), supported by investor relations through its corporate website (ausacap.com), press releases, email alerts, and participation in industry investor conferences such as the ROTH Conference and Spring Investor Summit. The customer base consists of portfolio companies rather than end consumers, with both upstream (capital, governance, public-company expertise) and downstream (strategic alignment, regulatory navigation, networks of thought leaders) value provided to investees operating in a capital-scarce, banking-restricted industry.

Name

Australis Capital

Legal name

Australis Capital Inc.

Website

https://ausacap.com

Company type

Public

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Australis Capital is a publicly traded cannabis-focused investment company (CSE: AUSA, OTCQB: AUSAF) that makes early-stage equity, debt, royalty, and control-share investments across the U.S. and international cannabis value chain, aligned with Aurora Cannabis and staffed by an experienced regulated-industry team.

Ownership category

akta.pro rank

Product category

Cannabis Investment Services

NAICS

Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239), Portfolio Management and Investment Advice (52394), Miscellaneous Intermediation (52391)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)

akta.pro primary industry

Geography-Focused Venture Capital (Regional/Emerging Markets) (FSANAAAE)

akta.pro secondary industry

Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG)

Keywords

• Cannabis investment
• Venture capital
• Growth equity
• Royalty financing
• Portfolio management

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Investment Returns: Australis Capital generates returns through equity investments, debt instruments, royalties, and other distribution streams from portfolio companies in the cannabis value chain. The company also pursues control share acquisitions and invests in both public and private cannabis companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Australis Capital is a publicly traded investment company that creates shareholder value through early-stage, opportunistic, and diversified investments in the cannabis value chain in the United States and abroad. Its capital deployment spans equity, debt, and other securities of public and private cannabis companies, financings in exchange for royalties or distribution streams, and control share acquisitions, with each investment reviewed on an ongoing basis for portfolio appropriateness.

Product overview

Australis Capital is an investment company focused on creating shareholder value through early-stage, opportunistic, and diversified investments in the cannabis value chain in the United States and abroad. Rather than operating a traditional product platform, the company identifies and invests in cannabis businesses through equity, debt, or other securities of public and private companies, financings in exchange for royalties or distribution streams, and control share acquisitions. Their investment approach is supported by alignment with Aurora Cannabis and leverages deep regulatory expertise in highly regulated industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Mr. Natural cannabis brand portfolio Cannabis consumer products under the Mr. Natural brand, including dried flower, edibles, topicals, extracts, and GPEN Gio cartridges, distributed to medical and recreational cannabis consumers in markets where the brand operates.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and flagship.

• Mr. Natural Inc.coreStrategic or Co-development Partner · 26 February 2019Australis Capital to acquire Mr. Natural Productions, Inc., a classic medical and recreational cannabis brand known for high quality, strong high-THC products with intense terpene profiles. All products are certified organic.
• Folium BiosciencescoreStrategic or Co-development Partner · 15 January 2019Australis Capital invested in Folium Biosciences, the largest vertically integrated producer, manufacturer, and distributor of hemp derived phytocannabinoids in the USA. Owns and operates the largest phytocannabinoid extraction and purification facility in the USA.
• Aurora CannabisflagshipStrategic or Co-development PartnerAurora is one of the largest and fastest growing cannabis companies in the world with a funded production capacity of over 500,000 kilograms per year. Australis Capital leverages its alignment with Aurora for strategic positioning and market credibility in the global cannabis industry.
• Rthm Technologies, Inc.coreStrategic or Co-development PartnerRthm has developed the #1 health app in 26 countries. They hold several brand-associated trademarks and have developed the world's first mobile genetics and circadian rhythm mapping platform for iOS and Android devices.
• Wagner DimascoreStrategic or Co-development PartnerNevada-based corporation developing technology for large scale manufacturing of hemp and cannabis pre-rolls and cones. Licensees have experienced significant demand with over 40 of the largest cannabis brands utilizing their proprietary hardware.
• Body and Mind Inc. (BaM)coreStrategic or Co-development PartnerPublicly traded company investing in high quality medical and recreational cannabis cultivation, production and retail. Wholly-owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses.
• ShowGrowcoreStrategic or Co-development PartnerBrand and dispensaries known for building customer-friendly dispensaries in high volume locations. Won OC Weekly's 2016 & 2017 Best Dispensary of the Year. Recently acquired by Body and Mind, Inc.
• Quality GreencoreStrategic or Co-development PartnerACMPR-Licensed Producer based in Canfield, Ontario founded in 2013. Strives for optimized production efficiency, best practices, and standards to produce the finest cannabis product.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Merida Capital Partners: Cannabis-focused private equity and venture firm investing across the cannabis value chain (cultivation, brands, ancillary). Highly comparable to Australis as a sector-specialist investment vehicle, with similar regulatory-driven barriers to mainstream capital.
• Poseidon Asset Management: Cannabis-focused fund manager running long-only and hedge strategies in public and private cannabis equities. Comparable to Australis as a dedicated cannabis-capital allocator with sector specialization and similar exposure to U.S. federal prohibition.
• Viridian Capital Advisors: Cannabis-focused financial advisory and investment banking firm publishing the Viridian Cannabis Deal Tracker. Directly comparable as a sector-specialist capital-markets intermediary serving similar clients and deal types.
• 4C Securities (Tuatara Capital): Cannabis-focused merchant bank and fund manager providing capital markets advisory and principal investing to the cannabis industry. Directly comparable to Australis given its role as an investor in Quality Green's going-public transaction and Mr. Natural acquisition.
• Phyto Partners: Early-stage cannabis venture fund with portfolio companies spanning cultivation, retail, and ancillary tech/services. Comparable as an opportunistic, diversified cannabis investor with similar deal-sourcing dynamics and sector concentration risk.

Broad incumbents

• Cresco Labs: Large publicly traded multi-state cannabis operator with vertically integrated wholesale and retail. Adjacent comparator — not a direct investment peer — but trades on a similar regulatory and capital-constrained thesis, providing a public-market read on the same drivers that affect Australis's portfolio.
• Green Thumb Industries: Publicly traded U.S. multi-state cannabis operator with national footprint. Adjacent comparator that helps anchor valuation multiples for U.S. cannabis exposure similar to that of Australis's portfolio companies.
• Aurora Cannabis: One of the largest publicly traded global cannabis producers and Australis's flagship strategic alignment partner. While not a peer in the investment-firm sense, Aurora's strategic relationship, capital-markets standing, and operational scale shape Australis's positioning.

Emerging players

• iAnthus Capital Holdings: Publicly traded multi-state cannabis operator with licensed cultivation, processing, and retail. Comparable to Australis's portfolio operators like Body and Mind/ShowGrow and Quality Green — overlapping customer base and shared exposure to U.S. state-by-state regulatory regime.

Others

• Canaccord Genuity (cannabis coverage): Investment bank with a dedicated cannabis equity research and capital markets practice. Comparable as a capital-formation intermediary in the cannabis sector; useful benchmark for transaction-fee economics that intersect Australis's transaction-based revenue model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/AustralisCapit1
• LinkedInlinkedin.com/company/australis-capital-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australis Capital